Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis

About this Attention Score

• In the top 5% of all research outputs scored by Altmetric
• Among the highest-scoring outputs from this source (#34 of 2,654)
• High Attention Score compared to outputs of the same age (96th percentile)
• High Attention Score compared to outputs of the same age and source (97th percentile)